{"id":909171,"date":"2023-08-18T09:20:42","date_gmt":"2023-08-18T09:20:42","guid":{"rendered":"https:\/\/teknomers.com\/es\/indya-2-tiene-leucemia-su-ultima-oportunidad-de-supervivencia-es-un-medicamento-experimental-pero-la-compania-farmaceutica-rechaza-a-los-padres\/"},"modified":"2023-08-18T09:20:46","modified_gmt":"2023-08-18T09:20:46","slug":"indya-2-tiene-leucemia-su-ultima-oportunidad-de-supervivencia-es-un-medicamento-experimental-pero-la-compania-farmaceutica-rechaza-a-los-padres","status":"publish","type":"post","link":"https:\/\/teknomers.com\/es\/indya-2-tiene-leucemia-su-ultima-oportunidad-de-supervivencia-es-un-medicamento-experimental-pero-la-compania-farmaceutica-rechaza-a-los-padres\/","title":{"rendered":"Indya (2) tiene leucemia, su \u00faltima oportunidad de supervivencia es un medicamento experimental, pero la compa\u00f1\u00eda farmac\u00e9utica rechaza a los padres."},"content":{"rendered":"\n<p>La peque\u00f1a Indya Lebbe (2) ha estado luchando contra la leucemia mieloide aguda (LMA), la forma m\u00e1s letal de la enfermedad, desde que ten\u00eda seis meses.  La ni\u00f1a ya se ha sometido a varios tratamientos y operaciones, pero en vano.  Seg\u00fan los m\u00e9dicos del hospital infantil de Los \u00c1ngeles, donde se encuentra internada desde hace un a\u00f1o, solo le quedan cuatro semanas de vida.  &#8220;Su \u00fanica esperanza en este momento es un f\u00e1rmaco experimental de Elucida Oncology llamado ELU-001&#8221;, dijo su padre flamenco, Dieter, de Los \u00c1ngeles.<br \/>\n<br \/><br \/>\n<br \/><a href=\"https:\/\/www.hln.be\/binnenland\/indya-2-heeft-leukemie-haar-laatste-kans-op-overleven-is-experimenteel-medicijn-maar-farmabedrijf-wimpelt-ouders-af~ab8acce7\/\" rel=\"nofollow noopener\" target=\"_blank\">ttn-es-3<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>La peque\u00f1a Indya Lebbe (2) ha estado luchando contra la leucemia mieloide aguda (LMA), la forma m\u00e1s letal<\/p>\n","protected":false},"author":1,"featured_media":909172,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[1333,10296,21097,200263,5500,36,29306,1727,227,267,11630,28926,324,1726],"class_list":["post-909171","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-general","tag-compania","tag-experimental","tag-farmaceutica","tag-indya","tag-leucemia","tag-los","tag-medicamento","tag-oportunidad","tag-padres","tag-pero","tag-rechaza","tag-supervivencia","tag-tiene","tag-ultima"],"_links":{"self":[{"href":"https:\/\/teknomers.com\/es\/wp-json\/wp\/v2\/posts\/909171","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/teknomers.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/teknomers.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/teknomers.com\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/teknomers.com\/es\/wp-json\/wp\/v2\/comments?post=909171"}],"version-history":[{"count":0,"href":"https:\/\/teknomers.com\/es\/wp-json\/wp\/v2\/posts\/909171\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/teknomers.com\/es\/wp-json\/wp\/v2\/media\/909172"}],"wp:attachment":[{"href":"https:\/\/teknomers.com\/es\/wp-json\/wp\/v2\/media?parent=909171"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/teknomers.com\/es\/wp-json\/wp\/v2\/categories?post=909171"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/teknomers.com\/es\/wp-json\/wp\/v2\/tags?post=909171"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}